[1]
2022. The frequency and spectrum of hereditary mutations in the TP53 gene in an extensive study involving Russian breast cancer patients. Voprosy onkologii. 68, 5 (Oct. 2022), 589–597. DOI:https://doi.org/10.37469/0507-3758-2022-68-5-589-597.